<DOC>
	<DOCNO>NCT00522470</DOCNO>
	<brief_summary>We aim evaluate effect rosiglitazone serum ghrelin peptide yy level diabetic woman .</brief_summary>
	<brief_title>Effects Rosiglitazone Serum Ghrelin Peptide YY Levels</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Rosiglitazone</mesh_term>
	<criteria>newly diagnose , drug naive woman type 2 diabetes presence severe cardiovascular disease ( eg , New York Heart Association class III IV congestive heart failure history myocardial infarction stroke ) presence thyroid , pituitary , nutritional , hepatic , renal , neoplastic disorder</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2008</verification_date>
</DOC>